Bryce Peterson, MD
Family Medicine · Bountiful, UTNPI 1932417300
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,200 of the $1,694 with a category attached, or 70.8%. Biohaven Pharmaceuticals, Inc. accounts for 70.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $1,211 and has fallen 71.6% since, to $344 in 2025.
Across 10 payments — averaging $169.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- Chiesi USA, Inc.$364
- Abbott$64
- AbbVie$28
- Johnson & Johnson$24
- Sanofi-aventis U.S. LLC$15
Across 1,643 payments — averaging $9736.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$13.3M
- Pfizer$1.3M
- Seqirus USA Inc$1.2M
- AstraZeneca$147K
- Genentech, Inc.$126K
- Johnson & Johnson$13K
What the payments were for
- Consulting fees$1,20071%
- Speaking & faculty fees$32519%
- Food & beverage$1308%
- Education$392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 1 | $1,200 |
| Chiesi USA, Inc. | 2 | $364 |
| Abbott | 3 | $64 |
| AbbVie | 2 | $28 |
| Johnson & Johnson | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- FILSUVEZ$325
How this compares
$1,694 in reported general payments places this provider in the 70th percentile of 928 family medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 89 | $126,356 |
| EliquisApixaban | 70 | $99,713 |
| MounjaroTirzepatide | 81 | $90,429 |
| OzempicSemaglutide | 53 | $87,952 |
| FarxigaDapagliflozin Propanediol | 63 | $80,036 |
| XareltoRivaroxaban | 70 | $71,463 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 34 | $39,343 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $39,250 |
| JardianceEmpagliflozin | 22 | $33,814 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $17,207 |
| MyrbetriqMirabegron | 16 | $16,640 |
| RybelsusSemaglutide | 16 | $13,036 |
| Omeprazole | 310 | $7,180 |
| Atorvastatin Calcium | 569 | $6,770 |
| Humalog Kwikpen U-100Insulin Lispro | 21 | $6,333 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $24 | $71,46370 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $15 | $39,34334 claims |
| AbbVieArmour Thyroid | $28 | $1,55913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 928 family medicine providers in Utah.
Other family medicine in Bountiful
- Scott EricksonBountiful$101K
- Allen FreestoneBountiful$9K
- Michael CobbleSandy$1.3M
- Thomas ClarkProvidence$332K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- Mark CacciamaniSalt Lake City$43K
- Clint MowerLehi$41K
- Russell AndersonTooele$30K
- Kirk OdonnellSalt Lake City$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.